PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...

Scientists have uncovered a critical weakness in prostate cancer’s defences. The disease relies on two enzymes, PDIA1 and PDIA5, to survive and resist treatment. When these enzymes are blocked, cancer ...

A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.

The health secretary says he will balance the arguments for and against mass testing ahead of a final decision due in March.

Consider this a PSA about PSA. Prostate cancer is the most common cancer in US men, excluding skin cancer, and the second-leading cause of male cancer deaths, after lung cancer. One in 6 men will be ...

NEW YORK (Reuters Health) - Men diagnosed with localized prostate cancer are more likely to be treated with proton beam therapy, a novel form of radiation therapy, if the technology is available ...

Men diagnosed with prostate cancer have traditionally faced two choices: Do nothing and hope the tumor doesn’t grow between ...

Survivorship in metastatic prostate cancer is seen as chronic management, focusing on quality of life through physical and emotional management. Carotuximab combined with Erleada shows a favorable ...

Dr. Daniel P. Petrylak discussed recent developments in prostate cancer care, emphasizing the importance of genetic testing and personalized treatment. Dr. Daniel P. Petrylak, a professor of Medicine ...

Medicus Pharma Ltd. (Nasdaq: MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets. The Company is ...

SYRACUSE, N.Y.--(BUSINESS WIRE)--Associated Medical Professionals (A.M.P.) announced today the availability of the ArteraAI Prostate Test, an AI-powered risk stratification tool to help personalize ...

Steam may be more powerful than you think. It smooths clothes and kills germs, but now doctors are testing it against cancer. At Keck Medicine of USC, part of a large nationwide study, researchers are ...